As a proof of concept, we focused on the insulin growth factor 1 receptor (IGF1R), a receptor tyrosine kinase that mediates growth factor signalling in various tissues and cancers and has previously been inhibited with therapeutic antibodies16. Here, NTRK1 is linked to cancer.